Merrill Lynch Offers Four Key Biotech Drug Updates
Biotech pipeline news and biotech drug news continues to hit. A report from Bank of America/Merrill Lynch is highlighting four small-cap to mid-cap biotech stocks with positive prescription trends so far ...Read Full Story »





